In the BioHarmony Drug Report Database

"Preview" Icon

Alcaftadine

Lastacaft (alcaftadine) is a small molecule pharmaceutical. Alcaftadine was first approved as Lastacaft on 2010-07-28. It is used to treat allergic conjunctivitis in the USA. Lastacaft’s patent is valid until 2027-12-23 (FDA).

 

Trade Name

 

Lastacaft
 

Common Name

 

alcaftadine
 

ChEMBL ID

 

CHEMBL1201747
 

Indication

 

allergic conjunctivitis
 

Drug Class

 

Image (chem structure or protein)

Alcaftadine structure rendering